Page results
-
This information explains what you can expect from your care at the AL Amyloidosis Treatment Centre.
-
Health and wellbeing information for people affected by cancer.
-
A directory of UK organisations which provide specialist support to anyone affected by cancer or a blood condition
-
Information on safer eating during treatment, for patients with blood cancer.
-
This page has been written to tell you more about an outpatient hysteroscopy, why it is being done and what it involves.
-
This booklet is designed for teenagers and young people. It explains what you can expect when you finish your treatment for Hodgkin lymphoma.
-
Irreversible Electroporation for Prostate Cancer (IRE or Nanoknife™) patient information page.
-
A number of tests are carried out by the routine haemostasis/haematology laboratories. These include full blood count, ESR, sickle cell and glandular fever screening, malaria antigen testing, blood films and acanthocytes, coagulation screens (INR/heparin monitoring), fibrinogen and D-dimers (DIC screening).
-
Macmillan Support and Information Service offer emotional support, advice and information to people affected by cancer and blood conditions.
-
This patient information contains contraceptive advice for patients who have received Sugammadex.
File results
-
FOI/2024/0664 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0666 - Non-emergency patient transport services (NEPTS) and pathology specimen courier services
-
FOI/2024/0661 - Maternity services for caesareans
-
FOI/2024/0668 - Doctors shifts covered by Physician Associates 01/04/2024-01/09/2024
-
FOI/2024/0669 - LIMS and digital pathology systems
-
FOI/2024/0673 - A&E visits/ treatment for rings stuck on fingers - May 2023-May 2024
-
FOI/2024/0681 - Postoperative infections associated with cataract surgery 2019/20-2022/23
-
FOI/2024/0683 - International recruitment for nurses, doctors and AHP/HSS
-
FOI/2024/0685 - Lunch/ dinner menus for patients
-
FOI/2024/0687 - Newly diagnosed patients with AML starting first line treatment - February-July 2024